Why Is INTEGRA LIFESCIENCES (IART) Stock Down Today?
By the Top Tier Newswire AI Desk · October 22, 2026 at 12:06 AM ET · reviewed against 16 wire stories
INTEGRA LIFESCIENCES (IART) is down -11.18% in the latest session. Our newswire has captured 16 stories on IART across 6 sources in the last 36 hours, with AI sentiment reading mixed (avg 47/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Integra Lifesciences shares fell 11.18% to $11.84 on October 21, 2026. The primary driver was a Q3 2026 earnings report where revenue missed estimates, compounded by ongoing supply disruptions at the company’s Cincinnati facility.
What Happened
Integra LifeSciences reported third-quarter 2026 adjusted earnings per share of $0.59, which beat the consensus estimate of $0.56. However, sales of $411.182 million fell short of the expected $414.120 million. The company attributed the revenue shortfall to a flooding event that disrupted operations at its Cincinnati facility. Management stated that this disruption is expected to extend into the second quarter of 2027.
Despite the operational strain, the company affirmed its full-year 2026 adjusted EPS guidance of $2.30 to $2.40 and sales guidance of $1.634 billion to $1.654 billion. For the fourth quarter, Integra projected adjusted EPS between $0.61 and $0.71 and sales between $413.000 million and $433.000 million. Both figures came in below analyst expectations. Kirby McInerney LLP announced that it is continuing an investigation into the company, inviting investors who lost money on IART investments to contact the firm.
What The Data Shows
The stock’s decline extends a broader downward trend, with the share price dropping 14.8% over the last eight sessions from $13.98 to $11.90. Integra currently trades within a 52-week range of $8.70 to $20.49. On the day of the earnings release, the stock printed 36 fresh 52-week lows. Fundamentals indicate a market capitalization of $1.0 billion with a beta of 1.21. The company remains unprofitable on a trailing twelve-month basis, with an EPS of -$0.10 and a net margin of -0.4%. Revenue growth over the same period was 1.6%.
What To Watch
Investors will monitor the company’s ability to mitigate the Cincinnati facility disruption as it extends into 2027. The coverage breadth includes 16 stories from six sources in the last 36 hours, highlighting the market’s focus on the balance between near-term strain and long-term resilience.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
AI sentiment, last 36h · averaged over 16 stories · 47/100 neutral
The headlines behind the move
Story flow · 8 stories on the wire, last 36h · hover or tap a dot for the headline
9h agoTipRanksBEARISH 42Earnings
Integra Lifesciences Balances Progress and Near-Term Strain
Integra Lifesciences (($IART)) has held its Q3 earnings call. Read on for the main highlights of the call. Integra Lifesciences’ latest earnings call struck a cauti...
12h agoBusiness InsiderBEARISH 34General
Integra LifeSciences Holdings Corporation Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your IART Investments
New York, New York--(Newsfile Corp. - October 21, 2026) - The law firm of Kirby McInerney LLP ...
15h agoSeeking AlphaBEARISH 38Earnings
Integra outlines $1.634B-$1.654B 2026 revenue outlook as Cincinnati disruption extends into Q2 2027
2026-10-21. The following slide deck was published by Integra LifeSciences Holdings Corporation in conjunction with their 2026 Q3 earnings call.
17h agoSeeking AlphaBEARISH 34Earnings
Integra Life falls as tissue reconstruction woes add to flooding worries in Q3
Integra LifeSciences (IART) stock falls as the company's Q3 2026 results disappoint investors amid a flooding event that disrupted its Cincinnati facility. Read more here.
17h agoThe Motley FoolBULLISH 58Earnings
Integra (IART) Q3 2026 Earnings Call Transcript
Cincinnati flooding hit revenue, but neurosurgery growth and refinancing support recovery.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →